ArticleClinical & translational immunology2026
An Ad26-MVA-BN-based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infections.
Selina Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.